Exelixis (EXEL) Non-Current Assets (2010 - 2026)

Exelixis' (EXEL) quarterly Non-Current Assets came in at $1.4 billion in Q2 2026, down 3.87% year-on-year from $1.4 billion in Q2 2025, and down 1.15% quarter-over-quarter from $1.4 billion in Q1 2026.

Exelixis (EXEL) Non-Current Assets (2010 - 2026) Analysis & Trends

Exelixis' Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.4 billion for Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 3.87% year-over-year to $1.4 billion in Q2 2026; TTM through Apr 2026 was $5.7 billion, a 1.38% increase from a year earlier, with the FY2026 full-year figure at $1.4 billion, down 5.34% from the prior year.
  • Non-Current Assets eased to $1.4 billion in Q2 2026 per EXEL's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.6 billion in Q4 2023 and bottomed at $811.4 million in Q2 2022.
  • The 5-year median for Non-Current Assets is $1.4 billion (2025), against an average of $1.4 billion.
  • Across the five-year window, Non-Current Assets soared 85.89% in 2022 and retreated 16.51% in 2024, its largest moves.
  • Year by year, Non-Current Assets stood at $1.5 billion in 2022, then rose by 11.82% to $1.6 billion in 2023, then decreased by 13.16% to $1.4 billion in 2024, then climbed by 0.76% to $1.4 billion in 2025, then decreased by 2.56% to $1.4 billion in 2026.
  • Per Business Quant, the three latest EXEL Non-Current Assets figures stand at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.4 billion (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 1.38 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 1.38 Bn
Jan 2, 2026 1.40 Bn
Oct 3, 2025 1.42 Bn
Jul 4, 2025 1.50 Bn
Apr 4, 2025 1.44 Bn
Jan 3, 2025 1.48 Bn
Sep 27, 2024 1.41 Bn
Jun 28, 2024 1.30 Bn
Mar 29, 2024 1.51 Bn
Dec 29, 2023 1.62 Bn
Sep 29, 2023 1.53 Bn
Jun 30, 2023 1.55 Bn
Mar 31, 2023 1.51 Bn
Dec 30, 2022 1.45 Bn
Sep 30, 2022 1.12 Bn
Jul 1, 2022 1.03 Bn
Apr 1, 2022 811.38 Mn
Dec 31, 2021 781.49 Mn
Oct 1, 2021 785.71 Mn
Jul 2, 2021 774.03 Mn